longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AIRS

AIRS
----

LongbridgeAI

AirSculpt Tech | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 42.9 M

Earnings Watch
Aug 10, 2026 at 10:11 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Revenue: As of FY2026 Q2, the actual value is USD 42.9 M, missing the estimate of USD 44.14 M.

EPS: As of FY2026 Q2, the actual value is USD -0.02.

EBIT: As of FY2026 Q2, the actual value is USD 1.014 M.

Second Quarter 2026 Financial Highlights

Revenue

AirSculpt Technologies, Inc. reported revenue of $42.9 million for the second quarter of 2026, marking a -3% decrease from $44.0 million in the fiscal year 2025 second quarter.

Net Loss

The net loss for the quarter was - $1.1 million, compared to a net loss of - $0.6 million in the fiscal year 2025 second quarter.

Adjusted EBITDA

Adjusted EBITDA was $4.9 million, down from $5.8 million in the fiscal year 2025 second quarter.

Adjusted EBITDA Margin

The Adjusted EBITDA margin was 11.5% for Q2 2026, compared to 13.3% for Q2 2025.

Loss from Operations

The company reported a loss from operations of - $29 thousand for Q2 2026, compared to an income from operations of $786 thousand in Q2 2025.

Interest Expense, Net

Net interest expense was $1,043 thousand in Q2 2026, down from $1,562 thousand in Q2 2025.

Operating Costs

Total operating expenses were $42,929 thousand in Q2 2026, a decrease from $43,226 thousand in Q2 2025. Cost of service was $16,567 thousand in Q2 2026, down from $17,201 thousand in Q2 2025. Selling, general and administrative expenses increased to $23,421 thousand in Q2 2026 from $22,671 thousand in Q2 2025. Depreciation and amortization was $2,941 thousand in Q2 2026, compared to $3,246 thousand in Q2 2025.

First Six Months 2026 Financial Highlights

Revenue

Revenue for the first six months of 2026 declined by -1.3% to $82.3 million from $83.4 million in the first six months of fiscal year 2025.

Net Loss

Net loss for the first six months was - $3.5 million, compared to - $3.4 million in the first six months of fiscal year 2025.

Adjusted EBITDA

Adjusted EBITDA was $8.2 million, down from $9.6 million in the first six months of fiscal year 2025.

Adjusted EBITDA Margin

The Adjusted EBITDA margin was 10.0% for YTD 2026, compared to 11.5% for YTD 2025.

Loss from Operations

The company reported a loss from operations of - $1,831 thousand for YTD 2026, compared to a loss of - $803 thousand in YTD 2025.

Interest Expense, Net

Net interest expense was $2,241 thousand in YTD 2026, down from $3,187 thousand in YTD 2025.

Operating Costs

Total operating expenses were $84,120 thousand in YTD 2026, a decrease from $84,186 thousand in YTD 2025. Cost of service was $32,155 thousand in YTD 2026, down from $33,151 thousand in YTD 2025. Selling, general and administrative expenses increased to $46,003 thousand in YTD 2026 from $44,439 thousand in YTD 2025. Depreciation and amortization was $5,962 thousand in YTD 2026, compared to $6,488 thousand in YTD 2025.

Operational Metrics

Case Volume

Case volume was 3,376 for Q2 2026, a -0.5% decrease from 3,392 in Q2 2025. For the first six months of 2026, case volume was 6,458, a -0.2% decrease from 6,468 in the prior year period.

Same Center Case Volume

Same center case volume grew by 1.0% in Q2 2026 and 1.1% year-to-date.

Same Center Sales

Same center sales were stable in Q2 2026 and flat year-to-date.

Revenue per Case

Revenue per case was $12,707 in Q2 2026, down from $12,975 in Q2 2025. For YTD 2026, revenue per case was $12,742, compared to $12,892 in YTD 2025.

Number of Facilities

As of June 30, 2026, the company operated 31 facilities, down from 32 facilities as of June 30, 2025.

Number of Total Procedure Rooms

The number of total procedure rooms was 65 as of June 30, 2026, compared to 67 as of June 30, 2025.

Strategic Initiatives

AirSculpt Technologies, Inc. advanced its plans to introduce new procedures, including an exclusive partnership with AlloClae to offer an innovative injectable adipose matrix.

Cash Flow Data

Net Cash Provided by (Used in) Operating Activities

For Q2 2026, net cash used in operating activities was - $1,238 thousand, compared to $4,984 thousand provided by operating activities in Q2 2025. For the first six months of 2026, net cash provided by operating activities was $4,033 thousand, down from $5,852 thousand in the prior year period.

Net Cash Provided by (Used in) Investing Activities

Net cash used in investing activities was - $228 thousand in Q2 2026, compared to - $265 thousand in Q2 2025. For the first six months of 2026, net cash used in investing activities was - $279 thousand, a decrease from - $2,166 thousand in the prior year period.

Net Cash Provided by (Used in) Financing Activities

Net cash provided by financing activities was $3,600 thousand in Q2 2026, compared to - $2,083 thousand used in financing activities in Q2 2025. For the first six months of 2026, net cash provided by financing activities was $6,621 thousand, compared to - $3,732 thousand used in financing activities in the prior year period.

Balance Sheet and Liquidity (as of June 30, 2026)

Cash and Cash Equivalents

The company had $18,824 thousand in cash and cash equivalents, an increase from $8,449 thousand as of December 31, 2025.

Gross Debt

Gross debt was approximately $44.2 million, following a reduction of approximately $30 million since the start of 2025.

Current Portion of Long-Term Debt

The current portion of long-term debt was $10,460 thousand, up from $5,460 thousand as of December 31, 2025.

Long-Term Debt, Net

Long-term debt, net, was $33,108 thousand, down from $50,585 thousand as of December 31, 2025.

Total Liabilities

Total liabilities were $88,449 thousand, compared to $99,592 thousand as of December 31, 2025.

Total Stockholders’ Equity

Total stockholders’ equity increased to $104,832 thousand from $87,712 thousand as of December 31, 2025.

Borrowing Capacity

AirSculpt Technologies, Inc. had $5.0 million of borrowing capacity under its revolving credit facility.

Debt Repayment

During Q2 2026, the company paid down $1.4 million of debt and raised an additional $5.0 million from an at-the-market offering program. On August 7, 2026, a $2.5 million term loan payment was made in connection with an amended term loan agreement extending its maturity to November 2027, with an additional $2.5 million payment required by September 30, 2026.

2026 Outlook

AirSculpt Technologies, Inc. is reaffirming its full year 2026 revenue at the lower end of its guidance range of approximately $151 million to $157 million. The company is reducing its adjusted EBITDA outlook to the range of approximately $12 million to $14 million. These forward-looking statements are subject to various risks and uncertainties.

Login to unlock5,980characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

AirSculpt Tech

AirSculpt Tech

AIRS.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--